Rates of germline genetic testing and DNA damage response mutations found through population-based recruitment of men with incident metastatic prostate cancer.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W4281693123
